Tower Research Capital (TRC)’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,225
| Closed | -$12.8K | – | 6394 |
|
|
2023
Q3 | $12.8K | Sell |
1,225
-87
| -7% | -$684 | ﹤0.01% | 3862 |
|
|
2023
Q2 | $7.15K | Buy |
1,312
+522
| +66% | +$4.9K | ﹤0.01% | 4615 |
|
|
2023
Q1 | $9K | Sell |
790
-300
| -28% | -$4K | ﹤0.01% | 4590 |
|
|
2022
Q4 | $9K | Buy |
1,090
+665
| +156% | +$17.2K | ﹤0.01% | 4330 |
|
|
2022
Q3 | $18K | Sell |
425
-257
| -38% | -$13.7K | ﹤0.01% | 4041 |
|
|
2022
Q2 | $35K | Buy |
682
+607
| +809% | +$29.9K | ﹤0.01% | 3232 |
|
|
2022
Q1 | $5K | Sell |
75
-69
| -48% | -$3.44K | ﹤0.01% | 5143 |
|
|
2021
Q4 | $8K | Buy |
144
+108
| +300% | +$7.58K | ﹤0.01% | 4850 |
|
|
2021
Q3 | $3K | Buy |
+36
| New | +$3.08K | ﹤0.01% | 5177 |
|
|
2021
Q2 | – | Sell |
-142
| Closed | -$17K | – | 6010 |
|
|
2021
Q1 | $17K | Sell |
142
-42
| -23% | -$5.92K | ﹤0.01% | 4027 |
|
|
2020
Q4 | $23K | Sell |
184
-291
| -61% | -$37.4K | ﹤0.01% | 3791 |
|
|
2020
Q3 | $55K | Buy |
475
+393
| +479% | +$48.4K | ﹤0.01% | 3501 |
|
|
2020
Q2 | $11K | Buy |
+82
| New | +$10K | ﹤0.01% | 3984 |
|
|
2019
Q4 | – | Sell |
-90
| Closed | -$13K | – | 4607 |
|
|
2019
Q3 | $13K | Sell |
90
-431
| -83% | -$79.8K | ﹤0.01% | 2794 |
|
|
2019
Q2 | $122K | Buy |
+521
| New | +$165K | 0.01% | 1077 |
|
Other funds holding AXLA
Tower Research Capital (TRC)'s AXLA Position: Q4 2023 in Review
Tower Research Capital (TRC) sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 1,225 shares — an estimated $12.8K sold.
Tower Research Capital (TRC) first reported a position in AXLA in Q2 2019 and held it in 15 quarters. The position peaked at $122K in Q2 2019. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Tower Research Capital (TRC) reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,225 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $12.8K.
- Tower Research Capital (TRC) first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Axcella Health Inc. Common Stock position peaked at $122K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.